Ameritas Investment Company’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Ameritas Investment Company’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-88	Closed	-$8.1K	–	2297
2021 Q1	$8.1K	Buy	+88	New	+$7.43K	﹤0.01%	1587
2020 Q2	–	Sell	-53	Closed	-$2K	–	1824
2020 Q1	$2K	Buy	+53	New	+$1.79K	﹤0.01%	1616
2019 Q4	–	Sell	-53	Closed	-$2K	–	1700
2019 Q3	$2K	Buy	+53	New	+$1.37K	﹤0.01%	1527
2019 Q2	–	Sell	-53	Closed	-$1K	–	984
2019 Q1	$1K	Buy	+53	New	+$1.26K	﹤0.01%	926

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Ameritas Investment Company's HZNP Position: Q2 2021 in Review

Ameritas Investment Company sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2021, closing a stake of 88 shares — an estimated $8.1K sold.

Ameritas Investment Company first reported a position in HZNP in Q1 2019 and held it in 4 quarters. The position peaked at $8.1K in Q1 2021. 526 funds tracked by Wall St. Rank hold HZNP as of Q2 2021.

Ameritas Investment Company reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2021 after selling out during the quarter.
Ameritas Investment Company sold 88 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2021, an estimated $8.1K.
Ameritas Investment Company first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2019 and held it in 4 quarters.
Ameritas Investment Company's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $8.1K in Q1 2021.
526 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.